122 results
Page 4 of 7
6-K
EX-99.3
1iz 7c46cxl8vm7jhca
23 Nov 20
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-l
6:04am
6-K
EX-99.1
76svnjxx5vukugnn
29 Oct 20
Current report (foreign)
6:02am
6-K
EX-99.2
9635x ow2
29 Oct 20
Current report (foreign)
6:02am
6-K
EX-99.1
uhwhj1
28 Aug 20
Mesoblast Well Prepared Ahead of First Potential US Product Launch
8:48pm
6-K
EX-99.2
iou6e3c
28 Aug 20
Mesoblast Well Prepared Ahead of First Potential US Product Launch
8:48pm
6-K
xio zj5wj
29 May 20
Current report (foreign)
12:00am
6-K
EX-99.2
dfkd67e2 37u8
29 May 20
Current report (foreign)
12:00am
6-K
m6uev5tvxwhxuc
28 Feb 20
Provided to the Asx Under Listing Rule 4.2A
12:00am
6-K
EX-99.2
wjaepurkv1r
22 Jan 20
Mesoblast Presents Commercial Plans at 2020 Biotech Showcase In San Francisco
4:49pm
6-K
EX-99.1
mdr3739sbh7pnty6hmvw
29 Nov 19
Current report (foreign)
6:47am
6-K
EX-99.2
aafzgnjdbynp0qko
29 Nov 19
Current report (foreign)
6:47am
6-K
91mjr5x hq
27 Nov 19
Current report (foreign)
6:04am
6-K
EX-99.2
k8hcmp55zjh
27 Nov 19
Continued Increase in Revenues and Strong Balance Sheet
6:04am
6-K
EX-99.2
dkzsgxea
1 Nov 19
Appointment of Joint Company Secretary
6:02am
6-K
EX-99.1
74plh86
21 Oct 19
Mesoblast and Lonza Enter into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy
8:19pm
6-K
EX-99.1
1udgq69
3 Oct 19
Current report (foreign)
6:03am
6-K
EX-99.2
m3f n5rzj
11 Sep 19
Current report (foreign)
6:35am
6-K
EX-99.1
eucmvv uzri8vkfd
6 Sep 19
Mesoblast Reports 2019 Full Year Results
6:35am